课题基金 / 基金详情

Engineering Protein Stability Through Phage-Assisted Continuous Evolution

Engineering Protein Stability Through Phage-Assisted Continuous Evolution
通过噬菌体辅助的连续进化工程蛋白质稳定性
批准号:
9273266
负责人:
Tina Wang
金额:
$5.71万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-05-01 至 2019-04-30

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): Protein stability is an important requirement for heterologous expression, biocatalysis, and therapeutic applications. However, the discovery of stabilizing protein mutations remains a challenge in the field of protein engineering. Identifying stabilizing mutations through rational design remains difficult due to the poor understanding of how sequence relates to stability. On the other hand, directed evolution methods, while requiring little prior knowledge of structure-activity relationships, have mainly relied on using fusion reporter constructs for selection of stable proteins. These approaches are limited by factors such as protein size and interference from the fused reporter. Additionally, in many cases only stability is selected for, which can lead to unintended consequences such as loss of protein activity. The proposed research seeks to develop a general method for rapidly evolving stable proteins while ensuring maintenance of protein activity through Phage-assisted continuous evolution (PACE). PACE allows hundreds of rounds of directed evolution to be performed within the space of a week with minimal researcher intervention. By linking negative selection to activation of the E. coli heat shock response sigma factor σ32, the proposed method will use PACE to select against destabilized proteins. Protein function can be maintained by simultaneously conducting positive selection for an activity of interest. After the proposed system is validated i proof-of-concept experiments, it will be applied to evolving intrabodies capable of binding to and neutralizing mutant huntingtin misfolding and cytotoxicity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金